Tiny radioactive seeds tested again for returning cancers

NCT ID NCT04540588

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a second round of treatment with tiny radioactive seeds (DaRT) could safely shrink or control skin, mouth, or soft tissue cancers that came back after the first treatment. Only 2 people took part, and researchers measured tumor response and side effects. Because it's so small, the results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Diffusing Alpha Radiation Emitters Therapy (DaRT) device
What this could lead to
If it works, this could offer a retreatment option for patients whose cancer returned after initial DaRT therapy.
What could go wrong
This is a very early study with only 2 participants, so results may not apply to others. Risks include radiation side effects and tumor progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUCOSAL NEOPLASM OF ORAL CAVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sharett institute, Hadassah University Hospital - Ein-Kerem

    Jerusalem, 91120, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.